Which vitamins and over‑the‑counter supplements should be used with caution in patients with C3 glomerulopathy?

Vitamins and OTC Supplements Requiring Caution in C3 Glomerulopathy

Patients with C3 glomerulopathy should exercise extreme caution with vitamin A supplementation and avoid exceeding recommended daily intake for vitamin C, while vitamin D supplementation requires careful monitoring for hypercalcemia.

High-Risk Supplements

Vitamin A – AVOID Supplementation

• Do not supplement vitamin A in C3G patients 1
• Vitamin A accumulates in CKD because retinol-binding protein (the transport protein) is normally catabolized in renal tubules—this process is impaired when glomerular function is compromised
• Pediatric dialysis patients without supplements showed serum vitamin A levels 3-fold greater than controls 1
• Risk of vitamin A toxicity is high when supplements are provided
• Limit total intake to the Dietary Reference Intake (DRI) only from food sources
• Supplementation should be "rarely recommended and limited to those with very low dietary intake" 1

Vitamin C – Use Cautiously with Dose Limits

• Do not exceed the DRI significantly (combined dietary and supplement intake) 1
• Excessive vitamin C intake (0.5 to 1 g/day in adults) causes increased oxalate concentrations in plasma and soft tissues 1
• This is particularly dangerous in glomerular disease where oxalate clearance may be impaired
• Low levels are common in CKD due to restricted fruit intake and potential dialysis losses, but over-supplementation poses greater risk than deficiency

Vitamin D – Monitor Closely for Hypercalcemia

• Vitamin D supplementation is often necessary in CKD but requires careful monitoring for hypercalcemia 1
• The development of hypercalcemia is evidence of excessive dosing 1
• Do not use calcitriol, alfacalcidol, or other synthetic active vitamin D analogs (doxercalciferol, paracalcitol) to treat 25(OH)D deficiency 1
• Use ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) only for nutritional vitamin D deficiency
• Monitor serum calcium and phosphorus at 1 month after initiation or dose change, then at least every 3 months 1

Moderate-Risk Supplements

High-Dose B Vitamins

• While B vitamin supplementation is often recommended in dialysis patients, folic acid doses of 2.5-5.0 mg/day have been used to lower homocysteine 1
• However, in dialysis patients, folate and vitamins B6 and B12 lower but do not normalize plasma homocysteine levels
• Avoid megadoses beyond therapeutic targets

Vitamin E

• No specific contraindication mentioned in guidelines, but fat-soluble vitamin accumulation is a theoretical concern in glomerular disease

Safe Supplements (When Indicated)

B-Complex Vitamins (Standard Doses)

• Pyridoxine (B6): 10 mg daily supplement recommended for dialysis patients 1
• Biotin (B8): Intake equal to DRI should be provided 1
• Cobalamin (B12): Most CKD patients have normal levels; supplementation rarely needed 1

Vitamin K

• No need for intake greater than DRI unless eating poorly and receiving long-term antibiotic therapy 1

Critical Monitoring Parameters

When any supplementation is used:

• Serum calcium and phosphorus (monthly initially, then every 3 months for vitamin D) 1
• 25(OH)D levels (yearly once replete) 1
• Vitamin A levels (if any concern for toxicity)
• Renal function (eGFR, proteinuria)

Common Pitfalls to Avoid

1. Assuming "natural" means safe: Many patients believe OTC supplements are harmless, but only 21% of CKD patients know potential side effects 2
2. Multivitamin formulations: These often contain vitamin A and excessive vitamin C—read labels carefully
3. Herbal supplements: The evidence provided does not address specific herbs, but these are commonly used 2 and may have unknown interactions with complement-mediated disease
4. Self-medication: 37% of patients decide to use supplements themselves without physician input 2

Clinical Approach

For all C3G patients:

• Review all current OTC supplements and vitamins
• Discontinue vitamin A-containing supplements immediately
• Limit vitamin C to DRI levels
• If vitamin D supplementation is needed, use ergocalciferol or cholecalciferol with close calcium/phosphorus monitoring
• Educate patients that kidney disease fundamentally changes how vitamins are handled
• Emphasize that physician oversight is essential before starting any supplement

The key principle is that glomerular disease impairs normal vitamin metabolism and clearance, making standard OTC doses potentially toxic, particularly for fat-soluble vitamins (A, D, E, K) and vitamin C.